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Abstract 
There are limited data on phosphorus balance and the effect of dietary calcium supplements on 
phosphorus balance in adolescents. The purpose of this study was to determine phosphorus 
balance and the effect of increasing dietary calcium intake with a supplement on net phosphorus 
absorption and balance in healthy adolescent girls. This study utilized stored urine, fecal, and 
diet samples from a previously conducted study that focused on calcium balance. Eleven healthy 
girls ages 11-14y participated in a randomized crossover study which consisted of two 3-week 
periods of a controlled diet with low (817 ± 62 mg/d) or high (1418 ± 35 mg/d) calcium, 
separated by a 1-week washout period. Phosphorus intake was controlled at the same level 
during both placebo and calcium supplementation (1531 ± 29 and 1534 ± 30 mg/d, respectively, 
p = 0.831). Mean phosphorus balance was positive by about 200 mg/day and was unaffected by 
the calcium supplement (p = 0.826). Urinary phosphorus excretion was lower with the calcium 
supplement (535 ± 42 vs 649 ± 41 mg/d, p = 0.013), but fecal phosphorus and net phosphorus 
absorption were not significantly different between placebo and calcium supplement (553 ± 60 
vs 678 ± 63 vs mg/d, p = 0.143; 876 ± 62 vs 774 ± 64 mg/d, p = 0.231, respectively). Dietary 
phosphorus underestimates using a nutrient database compared with the content measured 
chemically from meal composites by ~40%. These results show that phosphorus balance is 
positive in girls during adolescent growth and that a calcium dietary supplement to near the 
current recommended level does not affect phosphorus balance when phosphorus intake is at 
1,400 mg/d, a typical U.S. intake level. This article is protected by copyright. All rights reserved 
 
Keywords: Nutrition, phosphate metabolism, phosphorus balance, calcium metabolism, calcium 
supplementation 
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Introduction 
Because of rapid growth in adolescence, the phosphorus recommended dietary allowance 
(RDA) for girls and boys ages 9-13y is set at 1250 mg/day, nearly twice as high as the RDA of 
700 mg/day for adults (1). Data from the National Health and Nutrition Examination Survey 
(NHANES) show that the average intake of phosphorus in this age group for girls is 1176 
mg/day, and 66% of children in this age group meet the estimated average (median) requirement 
(2). Dietary calcium binds phosphorus in the intestine and impairs its absorption. The interaction 
between phosphorus and calcium in the intestine in healthy adults demonstrated that the 
phosphorus binding capacity of calcium carbonate and calcium acetate at approximately 45 mg 
phosphorus per gram calcium salt (3). Thus, calcium salts are used as phosphate binders to 
prevent or lower hyperphosphatemia in patients with CKD (4). 
Limited information exists on phosphorus balance and the effect of a dietary calcium 
supplement on phosphorus retention during adolescent growth to inform the phosphorus Dietary 
Reference Intakes (DRI) (5-7). This deficit in knowledge is particularly important because it is 
estimated from NHANES data that 24% of females aged 9-13 use supplemental calcium (8). 
 The aims of this study were to describe phosphorus balance in adolescent girls and      
determine the effect of a dietary calcium supplement on phosphorus skeletal retention using 
stored samples from a previous study that examined the effect of particle size of calcium 
supplementation on calcium balance (9). In addition, because of the uncertainty of the accuracy 
of dietary phosphorus intake from food composition tables, we tested the relationship between 
dietary intake estimated from food composition tables and from chemical analyses of the diet 
during the balance study. 
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Materials and Methods 
Subjects & Study Design 
Stored samples from adolescent girls who participated in calcium balance studies during 
the summer of 2007 were analyzed for phosphorus content. A detailed description of the original 
study is described elsewhere (9). Briefly, healthy adolescent girls, ages 11-14, participated in a 
randomized cross-over study that consisted of two three-week balance studies, separated by a 
one-week washout period to compare calcium balance in subjects when they were given small 
particle size calcium carbonate supplements, large particle size calcium carbonate supplements, 
or a placebo. The original study found no difference in calcium balance between small and large 
particle size calcium carbonate, but significantly greater positive calcium balance from small 
particle size than placebo (9). Eleven of the 12 participants who were in the study arm that 
compared small particle size calcium carbonate with placebo are included in the present analysis. 
(Table 1).  One participant was excluded from the present analysis due to insufficient stored 
fecal sample. Two of the 11 participants included completed only one of the two cross-over 
periods. Race and ethnicity were self-reported by questionnaire. Height and weight were 
measured with a stadiometer and scale and used to calculate height-for-age, weight-for-age, and 
BMI-for-age percentiles from the Centers for Disease Control (CDC) growth charts using the 
Statistical Analysis Software (SAS) files available online from CDC (10). Sexual maturation 
stage was determined by breast development using Tanner Sexual Maturity Form by self-
assessment (11). The balance studies were conducted in a controlled environment in the form of 
a summer camp. Participants were fed a controlled diet (containing ~800 mg/d calcium) and 
randomized to receive either an additional 600 mg/d of elemental calcium from calcium 
carbonate capsules or placebo (Figure 1). The controlled diet consisted of a 4-day cycle menu 
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with consistent phosphorus, calcium, sodium, and protein content. Participants were allowed to 
consume deionized water ad libitum. Diets of differing energy content (1300 kcal/d, 1600 kcal/d, 
and 1900 kcal/d) were designed to meet the energy requirements of the participants as estimated 
by the Harris-Benedict equation (12), and weekly body weights were monitored for weight 
maintenance. During each 3-week balance study, all fecal and urine samples were collected, and 
participants were closely monitored for diet, fecal, and urine collection compliance. Duplicate 
diet composites were made at the time of each meal, pooled by 24h, and frozen. Thawed 
composites were homogenized, freeze-dried (FTS Systems Inc., Stone Ridge, NY), and stored 
for later analysis. Any uneaten food was offered again to participants during the same 24h 
period, and complete intake was encouraged. Uneaten food at the end of the 24h period was 
saved, weighed, and analyzed to determine accurate intake. Polyethylene glycol (PEG), a 
nonabsorbable fecal marker, was provided with each meal (PEG E3350, Dow Chemical Co., 
Midland, MI, prepared in capsules by Delavau LLC). Pill counts, urine creatinine, and fecal PEG 
recovery were used as compliance measures as described previously (9).  
Measures 
Dietary, Fecal, and Urine Phosphorus Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
 Dietary phosphorus was estimated from study menus using Nutrition Data System for 
Research 2007 (NDSR, Nutrition Coordinating Center (NCC), University of Minnesota, 
Minneapolis, MN), and stored diet composite samples were analyzed for phosphorus. Freeze-
dried diet and thawed fecal homogenates (stored at -20°C) were ashed in a muffle furnace 
(Thermolyne Sybron Type 30400, Dubuque, IA) at 600°C. Ashed diet and fecal samples were 
diluted with 2% nitric acid. Acidified urine samples (stored at -40°C) were thawed and diluted 
with 2% nitric acid. Phosphorus was measured in diet, fecal, and urine samples by inductively 
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coupled plasma-optical emission spectrophotometry (ICP-OES; Optima 4300DV, Perkin Elmer, 
Shelton, CT). Daily urinary phosphorus excretion was adjusted based on average daily creatinine 
excretion (9) for each participant to correct for timing and incomplete sample collection errors. 
Phosphorus Balance and Net Absorption Calculations 
The first week of each 3-week study was used as an equilibration period to the calcium   
intake level, and balance calculations were based on the last two weeks of each 3-week study. 
For each balance period, balance, net absorption, and percent net absorption were calculated. 
Balance is calculated as dietary phosphorus intake (mg/d) minus urine and fecal phosphorus 
excretion (mg/d); net absorption as phosphorus intake (mg/d) minus fecal excretion (mg/d); and 
percent net absorption as net absorption (mg/d) divided by dietary intake (mg/d) x 100. 
Statistical Analysis 
Repeated measures ANOVA for crossover designs using the PROC MIXED procedure 
with subject as a random effect was used to compare treatment differences, and included analysis 
for order and period effects. Unpaired t-tests were used to compare estimated and analytically 
measured dietary phosphorus and calcium. Statistical significance was set at α < 0.05. Statistical 
Analysis Software (SAS Institute, Cary, NC) version 9.3 was used for all statistical analysis. 
Results are reported as mean ± SEM unless otherwise indicated. 
Results 
The majority of girls were of white race and non-Hispanic ethnicity (Table 1). BMI for 
age was greater than the 50th percentile. All were healthy and were recruited from Indiana, 
Illinois, and Ohio. 
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Phosphorus measured chemically in the daily diet samples from the placebo phase was 
and from the calcium carbonate was 39% and 40% greater than the phosphorus content estimated 
by NDSR (p < 0.001), respectively. Calcium measured in the diet samples was not different from 
estimated calcium content from NDSR in the placebo phase, and was 2% higher than estimated 
on the calcium phase (p = 0.013, Table 2). Dietary phosphorus intake measured chemically did 
not differ between placebo and calcium (p = 0.611, Table 2), and calcium intake was 
significantly different by design between placebo and calcium phases.  
Overall phosphorus balance was not different between calcium and placebo (245 ± 81 mg 
vs 228 ± 79 mg; p = 0.826) (Figure 2). Fecal phosphorus was not significantly different between 
calcium and placebo (678 ± 63 mg vs 553 ± 60 mg; p = 0.143, NS) while urinary phosphorus 
was 114 mg/d lower with calcium than with placebo (535 ± 42 mg vs 649 ± 41 mg, p = 0.013). 
Net phosphorus absorption was not significantly different on calcium compared with placebo 
expressed as either mg/d (774 ± 64 mg/d vs 876 ± 62 mg/d; p = 0.231, NS) (Figure 3, A) or as 
percent of intake (53 ± 4% vs 61 ± 4%; p = 0.186, NS).  
As previously reported (7), calcium balance was 307 mg/d higher on calcium compared 
to placebo, (519 ± 48 mg/d vs 212 ± 46 mg/d; p = 0.002), fecal calcium was higher (857 ± 56 
mg/d vs 517 ± 54 mg/d; p = 0.001), while urinary calcium was not significantly different (114 ± 
26 mg/d vs 84 ± 26 mg/d; p = 0.079, NS) (Figure 4). Net calcium absorption was higher (569 ± 
55 mg/d vs 301 ± 53 mg/d; p = 0.004) (Figure 3, B).  
Serum calcium, phosphate, 25OHD, 1,25-(OH)2D3, parathyroid hormone (PTH), 
osteocalcin, alkaline phosphatase (ALP), bone alkaline phosphatase (BAP), and urinary N-
terminal telopeptide (NTx) and free deoxypyridinoline (DPD) were not different between the 
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placebo and calcium (Table 3). Values were within normal ranges on both placebo and calcium 
supplement. 
Discussion 
 In this 3-week randomized, placebo-controlled crossover balance study, adolescent girls 
were in positive phosphorus balance of about 200 mg when consuming just over 1,400 mg of 
phosphorus per day. Because bone contains approximately 85% of the body phosphorus stores 
(13), the bulk of the retention is presumed to be in the skeleton reflecting the high rate of skeletal 
growth during adolescence. A calcium supplement of 600 mg/d had no effect on this phosphorus 
retention, but did increase the calcium retention by over 300 mg/d. In girls ages 9-13, average 
estimated calcium intake from the diet is 968 mg/d (8), and thus supplements may be used to 
achieve the calcium RDA of 1300 mg/d (14). The calcium supplement affected phosphorus 
metabolism in the expected direction by decreasing urinary phosphorus, but the decrease in net 
phosphorus absorption was not statistically significance. This may be attributable to the higher 
variability in fecal phosphorus measurements compared to urinary phosphorus. 
   
 Urinary phosphorus decreased by 1.9 per 10 mg/d increase in elemental calcium intake in 
the calcium carbonate period. In comparison, we previously published a study of similar design 
in moderate-stage CKD patients which showed that there was about 1 mg/d reduction in urinary 
phosphorus per 10 mg/d increase in elemental calcium (15) in the CKD study urinary phosphorus 
fell with calcium carbonate supplementation, but there was no increase in fecal phosphorus, net 
phosphorus absorption, or overall phosphorus balance. A study of pre-dialysis CKD patients also 
observed a ~1 mg/d reduction in urinary phosphorus per 10 mg/d calcium in patients receiving 
~800 mg elemental calcium (16). The difference in reduction in urine phosphorus with 
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supplemental calcium between our study in healthy adolescents and the CKD studies probably 
reflects increased efficiency to retain phosphorus in adolescents compared to adults with CKD. 
However, the lower amount of the calcium supplement, in the adolescent study which provided 
only ~600 mg/d may also be a factor. 
 
There are a limited number of phosphorus balance studies in adolescent girls using 
different levels of phosphorus and calcium intake. Nearly 100 years ago, Sherman et al. (7) 
performed a series of balance studies in 9-13 year old girls. Calcium intakes ranged from 425 to 
1794 mg/d with phosphorus intakes ranging from 886 to 2009 mg/d, and phosphorus balance 
ranged from -37 to 667 mg/d. Ca:P intake (mass) ratio ranged from 0.48 to 1.03, and  there is no  
relationship between Ca:P intake ratio and phosphorus or calcium balance. Over 50 years later, 
Greger et al. (5) provided 12.5 to 14.5 year old girls a diet of 1.07 g/d calcium, 0.85 g/d 
phosphorus and showed that phosphorus balance was positive (48 ± 76 mg/d) as was calcium 
balance (409 ± 61 mg/d). In a separate study by Greger et al. (6), phosphorus balance was similar 
to their previous study at 23 ± 110 mg/d. However, the DRIs for phosphorus for ages 9 through 
13 years were set based on estimated phosphorus intake to support observed tissue accretion 
rather than intakes for maximal retention because published studies lacked a range of phosphorus 
intakes to establish maximal retention as was available for calcium (1). Our study provides 
additional data at an intake level intermediate to other studies (~1.4 g/d phosphorus), but studies 
over a wider range of phosphorus intakes will be required to determine the intake that achieves 
maximal retention.  
Because 99% of the body’s calcium (17) and 85% of the body’s phosphorus (13) reside 
in bone as hydroxyapatite and assuming that during a three-week balance period retained 
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calcium and phosphate are deposited in the skeleton as apatite crystal, the relationship between 
calcium retention and phosphorus retention measured by balance should mirror the 2.15:1 mass 
ratio (5:3 molar ratio) of calcium to phosphorus in bone hydroxyapatite. On placebo, the mass 
ratio of the mean calcium balance to mean phosphorus balance is 1.08 and on calcium 
supplement is 2.47, which do not agree with the hydroxyapatite 2.15 ratio for placebo, but are 
close for the calcium supplement.  However, apart from two apparent outliers (one with very 
high calcium balance supplement but with no change in phosphorus balance, and one with very 
negative phosphorus balance on the calcium supplement) the individual subjects demonstrate 
that they do follow a slope similar to the expected ratio line (Figure 5) although the variation is 
high and some individuals appear to be higher or lower mineral retainers. This variation probably 
represents cumulative errors in the balance technique and differences in retention from natural 
variations in adolescent bone and soft tissue growth rates. It probably also reflects the fact that 
calcium phosphate is initially deposited in bone with a wide calcium to phosphate ratios (18).    
The observation in our study of an underestimation of dietary phosphorus by 
approximately 40% in mixed meals is consistent with other studies which have found 
underestimation of phosphorus content in nutrient databases spanning a wide range from ~15-
70% (19-24). Recently, Carrigan et al. (21) designed four-day menus to be low or high in 
phosphorus additives based on the absence or presence of phosphorus additives on food label 
ingredient lists, then analyzed these diets for phosphorus content and compared measured values 
with the estimated values from NDSR software and reported that NDSR underestimated 
phosphorus in these diets by ~14%. Other studies have evaluated the accuracy of nutrient 
database values for various meat products that list phosphate additives in the ingredients 
compared with those that do not. Sullivan et al. (22) analyzed the phosphorus content of 38 
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chicken products and found on average a 43% underestimation compared to the expected values. 
Benini et al (23) measured an average ~70% more phosphorus than estimated in ham, roast 
breast turkey, and roast breast chicken products from Italy. In our study, foods with phosphate 
additives listed on the ingredient label were matched as closely as possible to items in NDSR that 
also listed additive phosphate as an ingredient. It is clear that this method is insufficient to 
accurately estimate phosphorus content in mixed meals. To illustrate the potential impact of this 
error, we substituted the estimated dietary phosphorus from the nutrient database analysis in the 
balance calculations in this study. Doing so resulted in calculations of phosphorus balance of -
170 mg/d and -163 mg/d for the calcium carbonate and placebo periods, respectively. Without 
direct chemical analysis of the phosphorus content of the foods used in our balance studies, we 
would have erroneously concluded that our subjects were in negative phosphorus balance on 
both placebo and calcium supplement conditions. This underscores the importance of chemical 
analysis of diet composites in phosphorus balance studies. 
 This crossover balance study demonstrates that adolescent girls are in positive 
phosphorus balance of an average 200 mg/d on a diet of ~800 mg/d calcium and ~1400 mg/d 
phosphorus. When calcium intake is increased from ~800 mg/d to ~1400 mg/d with a calcium 
carbonate supplement, phosphorus balance is unchanged despite a more positive calcium 
balance. Increasing dietary calcium levels within a normal dietary range (from typical intake 
level to around the RDA level) does not negatively impact phosphorus balance when phosphorus 
intake is at a level typically consumed in the U.S. In addition, we confirm the need to improve 
estimations of phosphorus in foods in nutrient databases. 
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Figure Legends 
Figure 1. Randomized crossover study design. Twelve participants enrolled in the study. *1 
participant was randomized to the placebo-calcium sequence but did not start until the 2nd phase, 
so did not receive the placebo; 1 participant randomized to placebo-calcium sequence did not 
complete the 2nd phase of the crossover; 1 participant randomized to the placebo-calcium 
sequence is excluded from the present analysis due to insufficient stored fecal sample. Thus, n = 
11 are included in this analysis. 
 
Figure 2. Phosphorus balance in healthy adolescent girls on placebo versus calcium carbonate. 
 
Figure 3. A) Net phosphorus absorption in healthy adolescent girls on placebo versus calcium 
carbonate. B) Net calcium absorption in healthy adolescent girls on placebo versus calcium 
carbonate (n=11), data from Elble 2011 (9). 
Figure 4. Calcium balance in healthy adolescent girls on placebo versus calcium carbonate 
(n=11). Data from Elble 2011 (9). 
Figure 5.  Phosphorus and calcium balance in individual participants on placebo and calcium 
supplement. Ca:P mass ratio is given above each point, calculated from 99% Ca balance and 
85% P balance. For comparison, the expected 2.15:1 Ca:P mass ratio of bone hydroxyapatite is 
shown by the dashed line. 
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Tables 
 
Table 1. Baseline participant characteristics  
White/Asian, n 10/1 
Hispanic/Other, n 1/10 
Age, years 13.5 ± 0.98 (11.3-14.6) 
Height for age (percentile) 48.9 ± 29.1 (6.9-97.9) 
Weight for age (percentile)  60.1 ± 32.8 (2.9-98.9) 
BMI (kg/m2) 21.3 ± 2.8 (19.4-27.2) 
BMI for age (percentile) 62.3 ± 34.2 (6.2-97.1) 
Tanner stage, Breast (n for stages 1-5)* 0/2/3/2/2 
Mean ± SD. *Data missing for 2 participants 
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Table 2. Estimated and measured dietary phosphorus and calcium 
 Estimated 
Phosphorus (mg) 
 Measured 
Phosphorus 
(mg) 
Estimated 
Calcium 
(mg) 
Measured 
Calcium (mg) 
Diet with Placebo  
 
1031 ± 5.6  1435 ± 23.5** 784 ± 0.05  817 ± 19.5  
Diet with Calcium 
Carbonate 
1037 ± 7.4 1453 ± 28.0** 1384 ± 0.07#  1418 ± 11.1*# 
Mean ± SEM. *p < 0.05 measured calcium versus estimated calcium; ** p < 0.001 measured 
phosphorus versus estimated phosphorus; # p < 0.001 diet with placebo versus calcium 
carbonate.  
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Table 3. Hormone and bone metabolism markers on placebo and calcium supplement 
 
Values are presented as Mean (SEM). *To convert to mg/dL, divide Ca by 0.25 and P by 0.323. 
 
 
 Placebo Calcium P value 
Serum Ca 
(mmol/L*) 
2.275 (0.02) 2.28 (0.02) 0.764 
Serum P (mmol/L*) 1.49 (0.05) 1.42 (0.05) 0.208 
25OHD (nmol/L) 62.47 (4.7) 69.09 (5.0) 0.256 
1,25(OH)2D3 
(pmol/L) 
131.45 (8.9) 122.86 (8.9) 0.197 
PTH (pmol/L) 2.55 (0.29) 2.40 (0.31) 0.723 
Serum Osteocalcin 
(ug/L) 
21.71 (3.6) 24.58 (3.7) 0.494 
Serum BAP (ug/L) 73.39 (10.4) 81.25 (10.5) 0.120 
Serum ALP 
(ukat/L) 
2.86 (0.40) 2.87 (0.40) 0.958 
Urinary NTx (nmol 
BCE) 
3572.54 (1089.4) 4939.19 (1124.9) 0.290 
Urinary free-DPD 
(nmol) 
218.17 (35.6) 273.23 (36.8) 0.225 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 1. Randomized crossover study design. Twelve participants enrolled in the study. *1 participant was 
randomized to the placebo-calcium sequence but did not start until the 2nd phase, so did not receive the 
placebo; 1 participant randomized to placebo-calcium sequence did not complete the 2nd phase of the 
crossover; 1 participant randomized to the placebo-calcium sequence is excluded from the present analysis 
due to insufficient stored fecal sample. Thus, n = 11 are included in this analysis.  
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Figure 2. Phosphorus balance in healthy adolescent girls on placebo versus calcium carbonate.  
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Figure 3. A) Net phosphorus absorption in healthy adolescent girls on placebo versus calcium carbonate. B)
Net calcium absorption in healthy adolescent girls on placebo versus calcium carbonate (n=11), data from 
Elble 2011 (9).  
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Figure 4. Calcium balance in healthy adolescent girls on placebo versus calcium carbonate (n=11). Data 
from Elble 2011 (9).  
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Figure 5.  Phosphorus and calcium balance in individual participants on placebo and calcium supplement. 
Ca:P mass ratio is given above each point, calculated from 99% Ca balance and 85% P balance. For 
comparison, the expected 2.15:1 Ca:P mass ratio of bone hydroxyapatite is shown by the dashed line.  
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